questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CX3C
Chimiokines CX3C : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Chimiokines
Cytokines
Diagnostic
CX3CL1
CX3CR1
Marqueurs biologiques
Liquide céphalorachidien
Chimiokines
Pathologie
Maladies auto-immunes
Chimiokines
Inflammation
Biopsie
Chimiokines
Inflammation
Symptômes
5
Symptômes
Inflammation
Chimiokines
Douleur articulaire
Chimiokines
Inflammation
Système respiratoire
Chimiokines
Inflammation
Allergies
Chimiokines
Réponse immunitaire
Signes cliniques
Chimiokines
Inflammation
Prévention
5
Prévention
Chimiokines
Mode de vie sain
Vaccins
Chimiokines
Immunité
Maladies inflammatoires
Prévention
Stress
Hygiène
Chimiokines
Infections
Compléments alimentaires
Chimiokines
Régulation
Traitements
5
Thérapies biologiques
Chimiokines
Traitement
Anti-inflammatoires
Chimiokines
Inflammation
Corticostéroïdes
Chimiokines
Inflammation
Essais cliniques
Chimiokines
Traitement expérimental
Thérapie génique
Chimiokines
Traitement
Complications
5
Complications
Chimiokines
Maladies auto-immunes
Cancers
Chimiokines
Dysrégulation
Santé cardiovasculaire
Chimiokines
Inflammation
Complications neurologiques
Chimiokines
Sclérose en plaques
Infections
Chimiokines
Inflammation
Facteurs de risque
5
Facteurs de risque
Chimiokines
Obésité
Âge
Chimiokines
Inflammation
Infections
Chimiokines
Système immunitaire
Stress
Chimiokines
Inflammation
Habitudes alimentaires
Chimiokines
Graisses saturées
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokines CX3C : Questions médicales les plus fréquentes",
"headline": "Chimiokines CX3C : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokines CX3C : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokines CX3C"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chimiokines",
"url": "https://questionsmedicales.fr/mesh/D018925",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines",
"code": {
"@type": "MedicalCode",
"code": "D018925",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CX3CL1",
"alternateName": "Chemokine CX3CL1",
"url": "https://questionsmedicales.fr/mesh/D054428",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CX3CL1",
"code": {
"@type": "MedicalCode",
"code": "D054428",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.130.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines CX3C",
"alternateName": "Chemokines, CX3C",
"code": {
"@type": "MedicalCode",
"code": "D020523",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Noha Mousaad Elemam",
"url": "https://questionsmedicales.fr/author/Noha%20Mousaad%20Elemam",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "Azzam A Maghazachi",
"url": "https://questionsmedicales.fr/author/Azzam%20A%20Maghazachi",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "J Robert Lane",
"url": "https://questionsmedicales.fr/author/J%20Robert%20Lane",
"affiliation": {
"@type": "Organization",
"name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom."
}
},
{
"@type": "Person",
"name": "Meritxell Canals",
"url": "https://questionsmedicales.fr/author/Meritxell%20Canals",
"affiliation": {
"@type": "Organization",
"name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom."
}
},
{
"@type": "Person",
"name": "Martin J Stone",
"url": "https://questionsmedicales.fr/author/Martin%20J%20Stone",
"affiliation": {
"@type": "Organization",
"name": "Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[The virtual ILD board: a pilot project].",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37696286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2113-0556"
}
},
{
"@type": "ScholarlyArticle",
"name": "A realist review of dyslexia pilot project research.",
"datePublished": "2023-06-10",
"url": "https://questionsmedicales.fr/article/37300716",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11881-023-00284-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Quality Improvement Pilot Project for Noise Reduction in the NICU.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37018178",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ANC.0000000000001074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide Attempt Aftercare in Geriatric Patients: A Pilot Project.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36170052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01612840.2022.2127039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Adjunct Techniques in the Assessment of Hypovolemia: A Prospective Pilot Project.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37690381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2023.08.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CX3C",
"item": "https://questionsmedicales.fr/mesh/D020523"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokines CX3C - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokines CX3C",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokines CX3C",
"description": "Comment diagnostiquer une dysrégulation des chimiokines CX3C ?\nQuels marqueurs sont associés aux chimiokines CX3C ?\nLes chimiokines CX3C sont-elles mesurables dans le liquide céphalorachidien ?\nQuel rôle jouent les chimiokines CX3C dans les maladies auto-immunes ?\nPeut-on détecter les chimiokines CX3C dans les biopsies ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokines CX3C",
"description": "Quels symptômes sont liés à une surproduction de chimiokines CX3C ?\nLes chimiokines CX3C peuvent-elles causer des douleurs articulaires ?\nComment les chimiokines CX3C affectent-elles le système respiratoire ?\nLes chimiokines CX3C sont-elles impliquées dans les allergies ?\nQuels signes cliniques indiquent une activation des chimiokines CX3C ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokines CX3C",
"description": "Comment prévenir les maladies liées aux chimiokines CX3C ?\nLes vaccins influencent-ils les chimiokines CX3C ?\nY a-t-il des mesures préventives pour les maladies inflammatoires ?\nL'hygiène joue-t-elle un rôle dans la régulation des chimiokines CX3C ?\nLes compléments alimentaires peuvent-ils aider à réguler les chimiokines ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokines CX3C",
"description": "Quels traitements ciblent les chimiokines CX3C ?\nLes anti-inflammatoires affectent-ils les chimiokines CX3C ?\nComment les corticostéroïdes influencent-ils les chimiokines CX3C ?\nY a-t-il des traitements expérimentaux pour les chimiokines CX3C ?\nLes thérapies géniques peuvent-elles cibler les chimiokines CX3C ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokines CX3C",
"description": "Quelles complications peuvent survenir avec une surproduction de chimiokines CX3C ?\nLes chimiokines CX3C sont-elles liées à des cancers ?\nComment les chimiokines CX3C affectent-elles la santé cardiovasculaire ?\nLes complications neurologiques sont-elles possibles avec les chimiokines CX3C ?\nLes chimiokines CX3C peuvent-elles aggraver des infections ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokines CX3C",
"description": "Quels facteurs de risque sont associés aux chimiokines CX3C ?\nL'âge influence-t-il les niveaux de chimiokines CX3C ?\nLes infections antérieures augmentent-elles le risque lié aux chimiokines CX3C ?\nLe stress psychologique affecte-t-il les chimiokines CX3C ?\nLes habitudes alimentaires influencent-elles les chimiokines CX3C ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Pilot+Projects#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des chimiokines CX3C ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines peuvent aider à évaluer les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux chimiokines CX3C ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de CX3CL1 et de CX3CR1 sont souvent mesurés comme marqueurs d'inflammation."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C sont-elles mesurables dans le liquide céphalorachidien ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chimiokines CX3C peuvent être détectées dans le liquide céphalorachidien lors de certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les chimiokines CX3C dans les maladies auto-immunes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont souvent impliquées dans l'infiltration des cellules immunitaires dans les tissus affectés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les chimiokines CX3C dans les biopsies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent révéler des niveaux élevés de chimiokines CX3C dans les tissus enflammés."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surproduction de chimiokines CX3C ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent inflammation, douleur, et dysfonction immunitaire dans diverses maladies."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C peuvent-elles causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surproduction peut contribuer à l'inflammation et à la douleur dans les articulations."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CX3C affectent-elles le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer une inflammation des voies respiratoires, entraînant des symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C sont-elles impliquées dans les allergies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent jouer un rôle dans la réponse allergique en attirant les cellules immunitaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une activation des chimiokines CX3C ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur au site d'inflammation sont des signes cliniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux chimiokines CX3C ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les vaccins influencent-ils les chimiokines CX3C ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins peuvent moduler la réponse des chimiokines CX3C pour une meilleure immunité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les maladies inflammatoires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac et gérer le stress peuvent réduire le risque de maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "L'hygiène joue-t-elle un rôle dans la régulation des chimiokines CX3C ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène peut réduire les infections et, par conséquent, l'activation des chimiokines."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires peuvent-ils aider à réguler les chimiokines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments, comme les oméga-3, peuvent moduler l'activité des chimiokines CX3C."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les chimiokines CX3C ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques et des inhibiteurs de chimiokines sont utilisés pour moduler leur activité."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires affectent-ils les chimiokines CX3C ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires peuvent réduire la production de chimiokines CX3C dans l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les corticostéroïdes influencent-ils les chimiokines CX3C ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes diminuent l'expression des chimiokines CX3C, réduisant ainsi l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour les chimiokines CX3C ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent des inhibiteurs spécifiques des chimiokines CX3C."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles cibler les chimiokines CX3C ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches de thérapie génique sont en développement pour moduler l'expression des chimiokines."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une surproduction de chimiokines CX3C ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies auto-immunes, des allergies sévères et des infections chroniques."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C sont-elles liées à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation des chimiokines CX3C peut être associée à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CX3C affectent-elles la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à l'inflammation vasculaire, augmentant le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles avec les chimiokines CX3C ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent être impliqués dans des troubles neurologiques comme la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C peuvent-elles aggraver des infections ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une réponse inflammatoire excessive peut aggraver les infections et retarder la guérison."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux chimiokines CX3C ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de chimiokines CX3C ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut augmenter les niveaux de chimiokines CX3C, favorisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les infections antérieures augmentent-elles le risque lié aux chimiokines CX3C ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections passées peuvent sensibiliser le système immunitaire et augmenter les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Le stress psychologique affecte-t-il les chimiokines CX3C ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter la production de chimiokines CX3C, exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les chimiokines CX3C ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter les niveaux de chimiokines CX3C."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Chimiokines CX3C" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: chennh@imm.ac.cn.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, 67400 Illkirch, France.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS, Université de Strasbourg, 67400 Illkirch, France.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Chimiokines CX3C" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Publications dans "Chimiokines CX3C" :
Interstitial lung diseases are associated with high morbitity and mortality. Rapid diagnosis in a qualified center is necessary in order to provide the best possible treatment. However, geographic dis...
We conducted a realist review of state-authorized dyslexia pilot projects to understand how they have been implemented and evaluated, and the extent to which they adhere to best practice recommendatio...
Increased noxious noise leads to adverse short-term and long-term effects on the growing neonate. The American Academy of Pediatrics recommends maintaining a noise level of less than 45 decibels (dBA)...
The purpose of this pilot project was to reduce the average noise levels by 39% at the end of an 11-week period....
The location of the project was in a large, high-acuity level IV open-pod layout NICU that consisted of 4 pods, one of which was cardiac-focused. The average baseline noise level in the cardiac pod wa...
At the end of the project, noise levels decreased from 62.6 dBA to 54 dBA, a 13.7% reduction....
At the end of this pilot project it was noted that: Online modules were the best way to educate staff. Parents should be included in the implementation of quality improvement. Healthcare providers nee...
Hospitalized patients after suicide attempts gave informed consent to a postvention project after discharge. A continuous caregiver contacted the subjects monthly by phone for a period of 1 year. In c...
Measuring the hypovolemic resuscitation end point remains a critical care challenge. Our project compared clinical hypovolemia (CH) with three diagnostic adjuncts: 1) noninvasive cardiac output monito...
Adult trauma/surgical intensive care unit patients were prospectively screened for suspected hypovolemia after acute resuscitation, excluding patients with burns, known heart failure, or severe liver/...
44 patients (62% male, median age 60) yielded 65 measures. Positive agreement with CH was 47% for NICOM, 37% for US-IVC and 10% for US-C. None of the three adjuncts correlated with CH (κ -0.045 to 0.0...
None of the adjunct measurements correlated with CH or each other, highlighting that fluid status assessment remains challenging in critical care. US should assess for right ventricular dysfunction pr...
People living with chronic disease should ideally engage with community-based exercise services following hospital-based rehabilitation. However, transition from hospital to community exercise setting...
The aims of this study were to develop and explore the feasibility of a pilot exercise referral pathway between an acute hospital and community gyms for patients with chronic health conditions and to ...
A stakeholder-informed exercise referral pathway was developed and offered to patients following completion of a hospital-based exercise programme for a chronic health condition. The pathway was evalu...
Forty-nine people living with chronic conditions (mean age 72 ± 7.8 years) participated (recruitment rate 59%). The average number of community gym visits over 4 months was 17.4 (range 0-51). Twenty-n...
A structured exercise referral pathway to support exercise transition between hospital and community settings in populations with chronic health conditions appears feasible. Participants reported high...
This manuscript offers findings from a pilot project which prepares nursing students for embodied professional practice through the lens of ethics. Four undergraduate nursing students were mentored by...
Chlamydia disproportionately affects individuals aged 15-24 years. A lack of chlamydia knowledge in this high-risk group likely contributes to decreased testing, but interventions to increase chlamydi...
A pre- and post-test design was used to evaluate participant knowledge of chlamydia before and after completing a nurse-developed web-based education intervention designed for university students....
Forty-seven undergraduate students at one U.S. university participated. A focus group and scientific evidence informed the development of the web-based education....
Participants had a significant increase in chlamydia knowledge after completing the online educational intervention (M = 8.0, SD = 0.000) compared to baseline (M = 6.5, SD = 1.5), t(33) = -5.821, p < ...
In the twenty-first century, health systems have to cope with the challenges posed by their rapidly changing environment. Among these changes, the emergence of digital health solutions is an opportuni...
This study is based on a survey of the dental care provided by three units (Oral Medicine, Periodontology, Orthodontics) of the Department of Community Dentistry, Semmelweis University, Budapest. Duri...
According to our findings, teledentistry has the potential to shorten the visit with an average of 5-10 min per patient, which adds up to 58-116 work hours in a year. If the pilot was rolled out to al...
The rapid development of digital health technologies coupled with the evolving task distribution between health professionals have a great potential to improve health system performance in pursuit of ...
Obesity is a chronic, multifactorial disease which is linked to a number of adverse endocrinological and metabolic conditions. Currently, bariatric surgery is one of the most effective treatments for ...